| Page 161 | Kisaco Research
 

Jennifer Callahan

COO
ATRIO Health Plans

Jen Callahan is the President and Chief Operating Officer of ATRIO Health Plans. For over 20 years, Jen has established herself as a trusted thought leader who helped shape the managed care industry with her innovative ideas and expertise. Jen has dedicated her career almost exclusively to Medicare Advantage and Medicare Supplement programs.

Jennifer Callahan

COO
ATRIO Health Plans

Jennifer Callahan

COO
ATRIO Health Plans

Jen Callahan is the President and Chief Operating Officer of ATRIO Health Plans. For over 20 years, Jen has established herself as a trusted thought leader who helped shape the managed care industry with her innovative ideas and expertise. Jen has dedicated her career almost exclusively to Medicare Advantage and Medicare Supplement programs.

Prior to joining ATRIO, she co-founded a field management organization, Keen Insurance Services, Inc. to create a provider-centric Medicare focused sales and distribution organization from the ground up. Prior to that, she held the position of Vice President, Medicare Product at Aetna, a CVS Health company where she oversaw the product development and implementation of Aetna’s entire Medicare portfolio supporting record breaking growth for the Medicare organization. Throughout her career, Jen has also held various leadership positions at Healthfirst and Elevance.

Jen received her Bachelor of Science degree from Fordham University and MBA from North Carolina State University. Jen currently resides in Waxhaw, a suburb of Charlotte, North Carolina with her husband, their three kids, tuxedo cat, Vivi and golden retriever puppy, Steve.

 

Angela Zigler

Special Agent
Food and Drug Administration Office of Criminal Investigation

Angela Zigler

Special Agent
Food and Drug Administration Office of Criminal Investigation

Angela Zigler

Special Agent
Food and Drug Administration Office of Criminal Investigation

Russel Bagnall, Partner, Adams & Adams

The quality of the presentations was very high, and the content was very relevant. The conference was a good size-large enough to have meaningful network opportunities but still small enough to provide an intimate feel.

Maria Balestriero, IP Lawyer, Portolano Cavallo

Two inspiring days! Once again attending this conference proved to be to be a unique opportunity not only to see colleagues and friends from all over the world and for new connections, but also to catch up and discuss with them the latest developments in current topics in pharma and biotech patent litigation.

Michael Lee, Senior Director of Patents, Norgine

Brilliantly organised event, great mix of practice and industry attendees, a highly relevant and useful series of panel talks, and a good balance of networking and content.

Victoria Flowers, Executive Director Forensics, Mazars

The Pharma/Biotech Patent Litigation Europe Conference was very informative and offered many opportunities for networking with relevant contacts.

Christoph Rehfuess, Head of IP, Sotio

This was a thrilling event bringing together IP experts from originators, generics/biosimiars and judges into exciting panel discussions on the most immanent topics in Pharma/Biotech patent litigation.

Kit Carter, Global Head of IP Litigation, Sandoz

This has rapidly become the must go to event for pharma patent litigation. Not to be missed.

Georgia Roussou, Senior Legal Counsel, Win Medica

I believe it is the most interesting and useful conference for both lawyers and patent attorneys in the pharmaceutical industry.